You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (38)

Journals (0)

1-10 of 38 results for 5-HT3 antagonists

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists

Open access

Research article

First published 2024-10

Understanding Australian Pharmacists’ Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists

Aiden Hendry, Jack Janetzki, Wern Chern Chai

Journal of Pharmacy Practice

Select article: Effectiveness of Palonosetron Versus Other Serotonin 5-HT3 Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic Chemotherapy

Retricted access

Research article

First published 2012-12

Effectiveness of Palonosetron Versus Other Serotonin 5-HT3 Receptor Antagonists in Triple Antiemetic Regimens During Multiday Highly Emetogenic Chemotherapy

Kyung Im Kim, Dong Eun Lee, Inhye Cho [...]

Annals of Pharmacotherapy

Select article: 5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis

Open access

Research article

First published 2016-12

5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis

Chengmao Zhou, Yu Zhu, Zhen Liu [...]

Journal of International Medical Research

Select article: Cilansetron: A New Selective Serotonin Type 3 (5-HT3)-Receptor Antagonist for the Treatment of Irritable Bowel Syndrome in Males and Females

Retricted access

Research article

First published 2006-8

Cilansetron: A New Selective Serotonin Type 3 (5-HT3)-Receptor Antagonist for the Treatment of Irritable Bowel Syndrome in Males and Females

Brent A. Albertson

Hospital Pharmacy

Select article: Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of ‘overall’ nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients

Retricted access

Research article

First published 2016

Economic evaluation of 5-HT3 receptor antagonists in combination with dexamethasone for the prevention of ‘overall’ nausea and vomiting following highly emetogenic chemotherapy in Chinese adult patients

Qiong Du, Qing Zhai, Bin Zhu [...]

Journal of Oncology Pharmacy Practice

Select article: Prevention of Nausea and Vomiting in Cisplatin-Treated Patients by a Selective 5-Hydroxytryptamine (5-HT3) Receptor Antagonist,ICS 205-930

Retricted access

Research article

First published 1990-12

Prevention of Nausea and Vomiting in Cisplatin-Treated Patients by a Selective 5-Hydroxytryptamine (5-HT3) Receptor Antagonist,ICS 205-930

Luigi Dogliotti, Roberto Faggiuolo, Alfredo Berruti [...]

Tumori Journal

Select article: Possible anaphylaxis to palonoestron

Retricted access

Case report

First published 2012-6

Possible anaphylaxis to palonoestron

John M Pietkiewicz

Journal of Oncology Pharmacy Practice

Select article: Cancer Patients Submitted to Innovative Chemotherapeutic Agents of Intermediate Emetogenic Potential: Antiemetic Prescriptions and Incidence of Emesis

Retricted access

Other

First published 2004-1

Cancer Patients Submitted to Innovative Chemotherapeutic Agents of Intermediate Emetogenic Potential: Antiemetic Prescriptions and Incidence of Emesis

Verena De Angelis

Tumori Journal

Select article: A review of dolasetron as management of nausea and vomiting in cancer patients

Retricted access

Research article

First published 2000-9

A review of dolasetron as management of nausea and vomiting in cancer patients

Amy W. Valley

Journal of Oncology Pharmacy Practice

Select article: Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial

Retricted access

Research article

First published 2023-08

Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial

Hao Wei, Yu Sun, Lingling Xie [...]

Journal of Integrative and Complementary Medicine

1
2
3
4
10 / page

Article type

Publication date

Subjects

Access